FE fundinfo, the leading financial data company connecting the investment industry across the UK, Europe and Asia Pacific, ...

In one of South Asia’s fastest-growing economies, Bangladesh’s technology retail sector has emerged as a highly competitive ...

Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ...

Russell Bradley as President and General Manager of Plus Therapeutics' wholly owned subsidiary, CNSide Diagnostics, LLC ...

Q1 2026 Earnings Call Transcript May 28, 2025 nCino, Inc. reports earnings inline with expectations. Reported EPS is $0.16 ...

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (" 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.

TCS will showcase its role in shaping the future of the aerospace and defence industry and its commitment to sustainable aerospace transformation. Join us there.